Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of...

Area of Science:

• Cardiology
• Clinical Research
• Public Health

Background:

• The incidence of acute myocardial infarction (MI) in patients with prior coronary artery bypass grafting (CABG) is rising.
• Understanding the distinct characteristics and outcomes of this patient subgroup is crucial for effective management.

Purpose of the Study:

• To compare baseline characteristics, treatment patterns, and clinical outcomes of patients with and without prior CABG in the VALIANT trial.
• To identify specific needs for optimizing care in patients with prior CABG presenting with acute MI.

Main Methods:

• Analysis of data from the VALIANT trial, including 14,703 patients with heart failure or left ventricular systolic dysfunction.
• Comparison of demographic data, comorbidities, MI type, and acute treatment between patients with and without prior CABG.
• Evaluation of 3-year composite outcomes including cardiovascular death, MI, heart failure, cardiac arrest, and stroke.

Main Results:

• 7% of patients (1026) had prior CABG and were older with more comorbidities and non-Q wave MI.
• Patients with prior CABG received less aspirin and thrombolysis but similar rates of primary percutaneous coronary intervention.
• Prior CABG patients had significantly higher 3-year rates of the composite adverse outcome (64% vs. 39%).

Conclusions:

• Patients with prior CABG represent a high-risk population with poorer clinical profiles and worse outcomes post-MI.
• Enhanced recognition and optimization of evidence-based secondary preventive therapies are essential for this group.